Physician
Pediatric Practice Associates, P.C.
Pediatric Practice Associates, P.C. was paid $7.41M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoPEDIATRIC PRACTICE ASSOCIATES, P.C.
STAMFORD, CT 06905
STAMFORD, CT 06905
33aNPI1831386317assigned 09/28/2007
33bProvider typePediatrics Physician
28Total paid$7.41M
24GClaims189,729
24DCodes billed67
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Connecticut
Rank by total paid#11 of 162
Median peer was paid$313K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,764 | $1.06M | |
| 2019 | 28,373 | $1.15M | |
| 2020 | 25,391 | $1.01M | |
| 2021 | 24,979 | $1.11M | |
| 2022 | 25,967 | $1.06M | |
| 2023 | 27,732 | $1.03M | |
| 2024incomplete | 27,523 | $992K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 28,544 | 24,537 | $2.02M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 8,418 | 7,449 | $860K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.1% | 5,043 | 4,696 | $602K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.7% | 5,384 | 5,035 | $572K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.6% | 11,550 | 10,701 | $490K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.2% | 4,148 | 3,901 | $459K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.7% | 4,051 | 3,640 | $419K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.5% | 9,832 | 9,120 | $406K |
| 96127 | 3.2% | 11,013 | 9,953 | $237K | |
| 99177 | 2.9% | 11,318 | 10,703 | $211K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.4% | 7,087 | 6,759 | $174K |
| 92552 | 2.0% | 13,550 | 12,588 | $150K |
55 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.9% | 7,669 | $143K |
| 99188 | 1.5% | 5,913 | $114K | |
| 99174 | 1.1% | 4,296 | $83K | |
| 96161 | <1% | 3,935 | $66K | |
| 99051 | <1% | 9,116 | $60K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 395 | $41K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,248 | $37K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 756 | $36K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 3,253 | $32K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 1,429 | $32K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 386 | $28K |
| D1206 | Topical application of fluoride varnish | <1% | 1,258 | $22K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,683 | $18K |
| 99401 | <1% | 481 | $17K | |
| 99381 | <1% | 154 | $16K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 396 | $12K |
| 0072A | <1% | 205 | $8K | |
| 0071A | <1% | 203 | $8K | |
| 99443 | <1% | 130 | $7K | |
| 99173 | <1% | 1,407 | $7K | |
| 87634 | <1% | 74 | $5K | |
| 90677 | <1% | 519 | $3K | |
| 87807 | <1% | 231 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 28 | $2K |
| 0003A | <1% | 44 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 91 | $753.28 |
| 0001A | <1% | 18 | $720.00 | |
| 99442 | <1% | 15 | $643.95 | |
| 0002A | <1% | 15 | $600.00 | |
| 94760 | <1% | 17 | $28.22 | |
| 90686 | <1% | 9,993 | $0.01 | |
| 90633 | 0% | 1,232 | $0.00 | |
| 90670 | 0% | 2,288 | $0.00 | |
| 90715 | 0% | 311 | $0.00 | |
| 90707 | 0% | 174 | $0.00 | |
| 90734 | 0% | 1,284 | $0.00 | |
| 90648 | 0% | 155 | $0.00 | |
| 90681 | 0% | 870 | $0.00 | |
| 90461 | 0% | 66 | $0.00 | |
| 99072 | 0% | 103 | $0.00 | |
| 90710 | 0% | 257 | $0.00 | |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | 0% | 41 | $0.00 |
| 90685 | 0% | 12 | $0.00 | |
| 91300 | 0% | 115 | $0.00 | |
| 90697 | 0% | 899 | $0.00 | |
| 90620 | 0% | 732 | $0.00 | |
| 90651 | 0% | 1,585 | $0.00 | |
| 90723 | 0% | 147 | $0.00 | |
| 90698 | 0% | 885 | $0.00 | |
| A7015 | Aerosol mask, used with dme nebulizer | 0% | 41 | $0.00 |
| 90716 | 0% | 242 | $0.00 | |
| 90696 | 0% | 265 | $0.00 | |
| 91307 | 0% | 474 | $0.00 | |
| 90744 | 0% | 243 | $0.00 | |
| 90381 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLANCMAN, HAYDEE (OWNER)